Form 8-K ATOSSA GENETICS INC For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Atossa Genetics (ATOS) Reports Q3 Loss of $0.15/Share
November 12, 2015 4:05 PM ESTAtossa Genetics (NASDAQ: ATOS) reported Q3 EPS of ($0.15), versus ($0.13) reported last year. Revenue for the quarter came in at $772.2 thousand, versus $3.4 thousand reported last year.
Announced today that the National Cancer Institute, Division of Cancer Prevention, has approved a Letter of... More
